DIVIDEND ANNOUNCEMENT: GraniteShares YieldBOOST CRCL ETF/GraniteShares ETF Trust (NASDAQ:CRY) on 06/11/2026 declared a dividend of $0.4041 per share

GraniteShares YieldBOOST CRCL ETF/GraniteShares ETF Trust (NASDAQ:CRY) on 06/11/2026 declared a dividend of $ 0.4041 per share payable on June 16, 2026 to shareholders of record as of June 12, 2026. Dividend amount recorded is an increase of $ 0.0022 from last dividend Paid.

GraniteShares YieldBOOST CRCL ETF/GraniteShares ETF Trust (NASDAQ:CRY) has paid dividends since 2012, has a current dividend yield of 12.0805997849% and has increased its dividends for 0 successive years.

The stock price closed yesterday at $ 22.27 and has a 52 week low/high of $ 22.03 and $ 25.92.

CryoLife is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. Co. has the following product families: BioGlue® Surgical Adhesive products, JOTEC stent grafts and surgical products, On-X mechanical heart valves and surgical products, and implantable cardiac and vascular human tissues. Co.'s medical devices and preservation services are primarily used by cardiac and vascular surgeons to treat patients with aortic disease, including heart valve disease, and to a lesser extent, other conditions in cardiac and vascular surgery.

For more information on GraniteShares YieldBOOST CRCL ETF/GraniteShares ETF Trust click here.